Tiff Advisory Services LLC Purchases New Stake in SPDR S&P Biotech ETF $XBI

Tiff Advisory Services LLC acquired a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the third quarter, Holdings Channel.com reports. The institutional investor acquired 86,000 shares of the exchange traded fund’s stock, valued at approximately $8,617,000. SPDR S&P Biotech ETF makes up about 1.8% of Tiff Advisory Services LLC’s holdings, making the stock its 10th biggest holding.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in XBI. JPMorgan Chase & Co. grew its position in shares of SPDR S&P Biotech ETF by 2.6% during the 2nd quarter. JPMorgan Chase & Co. now owns 10,638,105 shares of the exchange traded fund’s stock valued at $882,218,000 after acquiring an additional 268,399 shares during the period. Bessemer Group Inc. grew its holdings in SPDR S&P Biotech ETF by 9.3% during the third quarter. Bessemer Group Inc. now owns 1,632,988 shares of the exchange traded fund’s stock valued at $163,624,000 after purchasing an additional 138,322 shares during the period. Ameriprise Financial Inc. grew its holdings in SPDR S&P Biotech ETF by 123.0% during the second quarter. Ameriprise Financial Inc. now owns 872,796 shares of the exchange traded fund’s stock valued at $72,542,000 after purchasing an additional 481,408 shares during the period. Meitav Investment House Ltd. increased its position in SPDR S&P Biotech ETF by 70.3% in the third quarter. Meitav Investment House Ltd. now owns 682,056 shares of the exchange traded fund’s stock worth $68,156,000 after buying an additional 281,602 shares during the last quarter. Finally, Greenhouse Funds LLLP raised its stake in shares of SPDR S&P Biotech ETF by 17.3% in the second quarter. Greenhouse Funds LLLP now owns 579,667 shares of the exchange traded fund’s stock valued at $48,072,000 after buying an additional 85,422 shares during the period.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA XBI opened at $122.86 on Friday. The stock has a market capitalization of $8.21 billion, a PE ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a one year low of $66.66 and a one year high of $132.09. The business’s fifty day moving average price is $124.42 and its 200-day moving average price is $109.73.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.